Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MATClinics is a specialized healthcare provider focused on treating opioid use disorder and other substance use disorders through Medication-Assisted Treatment (MAT). The company operates several outpatient clinics across Maryland, offering a combination of FDA-approved medications, such as buprenorphine and naltrexone, alongside comprehensive counseling and behavioral therapy. Their approach emphasizes a low-barrier, patient-centered model designed to improve long-term recovery outcomes and reduce the risk of overdose. By integrating medical management with psychological support, MATClinics addresses both the physiological and behavioral aspects of addiction. The organization provides both in-person and telehealth services to ensure broad access to care for patients in various stages of recovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MATClinics.